Premium
Digest
Publication year - 2012
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.252
Subject(s) - perampanel , partial epilepsy , epilepsy , medicine , antagonist , adjunctive treatment , partial seizures , psychology , pediatrics , anesthesia , psychiatry , receptor
Perampanel (Fycompa), an AMPAtype glutamate receptor antagonist, developed by Eisai has been launched as the first in a new class of treatment for uncontrolled partial epilepsy. It is indicated as an adjunctive treatment for partial onset seizures, with or without secondarily generalised seizures, in people with epilepsy aged 12 years and older.